Last reviewed · How we verify
Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis
Approved treatments
- Lopid · Pfizer Inc.
Clinical guidelines
- FDA label — adj
Gemfibrozil therapy may be considered for those subjects with triglyceride elevations between 1,000 and 2,000 mg/dL who have a history of pancreatitis or of recurrent abdominal pain typical of pancreatitis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis treatment landscape brief
- Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis treatment updates RSS
Frequently asked questions about Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis
What drugs treat Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis?
Tracked treatments include Lopid.
What is the treatment for Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis?
Standard treatment for Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis includes Lopid. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis?
FDA label publishes guidelines for Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis. 1 guideline references tracked.
Related
- Treatment landscape: Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis patent cliff · Treatment of adult patients with triglyceride elevations between 1,000-2,000 mg/dL and history of pancreatitis or recurrent abdominal pain typical of pancreatitis CI report
- Treatment: Lopid · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing